about
Zika Virus: Implications for Public HealthDynamics of Persistent TT Virus Infection, as Determined in Patients Treated with Alpha Interferon for Concomitant Hepatitis C Virus InfectionTorquetenovirus infection and ciliary dysmotility in children with recurrent pneumonia.Env-expressing autologous T lymphocytes induce neutralizing antibody and afford marked protection against feline immunodeficiency virusDuring readaptation in vivo, a tissue culture-adapted strain of feline immunodeficiency virus reverts to broad neutralization resistance at different times in individual hosts but through changes at the same position of the surface glycoprotein.High prevalence of TT virus (TTV) and TTV-like minivirus in cervical swabsMolecular properties, biology, and clinical implications of TT virus, a recently identified widespread infectious agent of humansRole of hematopoietic cells in the maintenance of chronic human torquetenovirus plasma viremia.Relationships between total plasma load of torquetenovirus (TTV) and TTV genogroups carried.TT virus in the nasal secretions of children with acute respiratory diseases: relations to viremia and disease severityInvestigation on torquetenovirus (TTV) microRNA transcriptome in vivo.High prevalence of co-infection with multiple Torque teno sus virus species in Italian pig herds.Torque teno virus viremia load size in patients with selected congenital defects of innate immunity.Inclusion of rituximab in treatment protocols for non-Hodgkin's lymphomas and risk for progressive multifocal leukoencephalopathyEmergence of exhausted B cells in asymptomatic HIV-1-infected patients naïve for HAART is related to reduced immune surveillance.Human gyrovirus DNA in human blood, Italy.Torquetenovirus: the human virome from bench to bedside.A lentiviral vector-based, herpes simplex virus 1 (HSV-1) glycoprotein B vaccine affords cross-protection against HSV-1 and HSV-2 genital infections.Hyperbaric oxygen therapy in BKV-associated hemorrhagic cystitis refractory to intravenous and intravesical cidofovir: case report and review of literature.A multidisciplinary approach to study a couple of monozygotic twins discordant for the chronic fatigue syndrome: a focus on potential salivary biomarkers.Progressive multifocal leukoencephalopathy: what's new?Human anelloviruses and the central nervous system.Immunosuppressive monoclonal antibodies: current and next generation.Cell therapies for treatment of human immunodeficiency virus infection.In vitro sensitivity of human metapneumovirus to type I interferons.Human metapneumovirus associated with respiratory tract infections in a 3-year study of nasal swabs from infants in Italy.TT virus loads and lymphocyte subpopulations in children with acute respiratory diseases.Dynamics of Torque Teno virus plasma DNAemia in allogeneic stem cell transplant recipients.Graves' orbitopathy, idiopathic orbital inflammatory pseudotumor and Epstein-Barr virus infection: a serological and molecular study.Cyclovirus Vietnam DNA in immunodeficient patients.How Current Direct-Acting Antiviral and Novel Cell Culture Systems for HCV are Shaping Therapy and Molecular Diagnosis of Chronic HCV Infection?Lack of usutu virus RNA in cerebrospinal fluid of patients with encephalitis of unknown etiology, Tuscany, Italy.Rapid increase in total torquetenovirus (TTV) plasma viremia load reveals an apparently transient superinfection by a TTV of a novel group 2 genotype.Short-term kinetics of torque teno virus viraemia after induction immunosuppression confirm T lymphocytes as the main replication-competent cells.Torque teno virus (TTV) in multiple sclerosis patients with different patterns of disease.Immune complexed (IC) hepatitis C virus (HCV) in chronically and acutely HCV-infected patients.Comparative evaluation of five rapid methods for identifying subtype 1b and 2c hepatitis C virus isolates.Influence of hepatitis C virus (HCV) genotype, HCV RNA load, and alanine aminotransferase level on reduction of HCV RNA after a single administration of interferon-alpha.Rapid changes in hepatitis C virus quasispecies produced by a single dose of IFN-alpha in chronically infected patients.Lymphotropic polyomavirus and progressive multifocal leukoencephalopathy.
P50
Q27010617-51E6D99F-9342-4D07-A962-83454FD71F96Q27469997-E8C62F88-16FB-45DA-B870-ABD20B4CDB0EQ33325127-51D3CB33-6974-40F3-A91D-B85B8C458147Q33769283-DD4E3838-8761-4CC0-99AE-DE4C769ED157Q33840406-78F4BE4B-9C8A-4803-A326-7B8096AE451BQ33972407-FEC669B9-D9BF-4D45-AA34-C96548E72169Q33975622-C140ED51-3BED-4B1F-BE65-91E9EE59EAC3Q33990669-DB90D0C2-B0CB-436A-9AFC-63A1A4746BC1Q34042218-F335050F-2B78-4F52-9C57-317BCEEC5965Q34470729-03A4DAD0-FC95-4411-BE81-03A6985B19D8Q34517488-280CF45B-18BD-4764-9CC1-5B8EDE03B901Q34550106-39D7F3A3-7C45-44E8-BED7-64DE7E4E4776Q35066335-4C829EFE-A95E-4C3E-AA94-B6D2E4B2EE6AQ35583773-E4098F64-7751-4A80-8971-B43164945459Q35830092-9DFD6A4E-B6E9-46DD-BB5D-5181F4E7C8AAQ35980004-D70F8F04-6FAF-498D-81D3-65220681BB6DQ35993934-175ECE3A-4924-41FE-BF00-3B3770BB49E8Q36086635-4CBE891C-F2C6-45F9-BA63-71AAB43DEC92Q37227215-826D4416-9277-476B-9ECD-2F6CB1EFF7B2Q37363077-D0CB3740-9D41-4A9A-A7A9-4464E996B288Q37755922-8DAFAFF7-0DF6-41AC-8D58-F5746AE55B62Q37798230-C42DB97C-84A2-4A40-AA73-02EDC039D305Q37945263-6EEB4561-8356-4DB8-AD4D-694AE4DDA34BQ38366376-A12A7E4B-A108-43EE-A120-E604D471B36AQ39568312-183E9FEE-D0B9-403B-B52E-62F78CA7D226Q39789769-A6635160-D23A-4AC7-8793-D1634913F2B4Q39796571-8108ED1F-77C3-40B5-9829-2EA61FD8D307Q40121730-84E953EE-1A59-46D1-8326-C82552B77007Q40405974-32F2F40C-1831-4703-86AA-0DF5F9526704Q40642672-31326190-A4C0-4468-8EAD-D7FEF7B0C949Q41070523-BF1F0CBB-BB77-479F-8BC4-E85AB11D4621Q41465492-4D152DBD-4118-4639-949D-304191D86C92Q41481733-252AF1E8-DDF8-4ABD-9CF9-B5B2F42A34ADQ41705875-C6F11339-DEAB-4B46-851F-6CD2A236A01DQ42275574-F4981B2E-310D-4B0A-9CB4-FD081E4D97ECQ42980735-F99CC3CE-081F-4538-A3B8-C4A9FFDBD53DQ42984237-885BC995-0EFB-4E3B-8F4A-A98C6904EA8CQ42995108-7501FCAD-D24A-44AE-9078-B01410B76900Q43032661-F6C06EF0-27DF-4D41-83FC-7C857867A226Q43203780-DCBD83C7-6BA0-459E-B701-A8C0AA1BD538
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Fabrizio Maggi
@ast
Fabrizio Maggi
@en
Fabrizio Maggi
@es
Fabrizio Maggi
@nl
Fabrizio Maggi
@sl
type
label
Fabrizio Maggi
@ast
Fabrizio Maggi
@en
Fabrizio Maggi
@es
Fabrizio Maggi
@nl
Fabrizio Maggi
@sl
prefLabel
Fabrizio Maggi
@ast
Fabrizio Maggi
@en
Fabrizio Maggi
@es
Fabrizio Maggi
@nl
Fabrizio Maggi
@sl
P106
P1153
7007009685
P31
P496
0000-0001-7489-5271